Personalising Alzheimer's Disease progression using brain atrophy markers.

Verdi, Serena; Rutherford, Saige; Fraza, Charlotte; Tosun, Duygu; Altmann, Andre; Raket, Lars Lau; Schott, Jonathan M; Marquand, Andre F; Cole, James H

Verdi, Serena; Rutherford, Saige; Fraza, Charlotte; Tosun, Duygu; Altmann, Andre; Raket, Lars Lau; Schott, Jonathan M; Marquand, Andre F; Cole, James H.

Afiliação

Verdi S; Centre for Medical Image Computing, University College London, London, UK.
Rutherford S; Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.
Fraza C; Donders Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, 6525EN, the Netherlands.
Tosun D; Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, 6525EN, the Netherlands.
Altmann A; Donders Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, 6525EN, the Netherlands.
Raket LL; Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, 6525EN, the Netherlands.
Schott JM; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
Marquand AF; Centre for Medical Image Computing, University College London, London, UK.
Cole JH; Department of Clinical Sciences, Lund University, Lund, Sweden.

medRxiv ; 2023 Jun 16.

Article em En | MEDLINE | ID: mdl-37398392

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google